GRIA1 and nervous system disorder: Liquid chromatography–tandem mass spectrometry and immunoelectron microscopy of GluA1 immunoisolated ACVs revealed several potential new candidates with connections to AMPAR trafficking and neurological disease (Figures 2, 3 and Table 1).